Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Withdrawn before enrolling · Not applicable

Conditions studied: Allo-SCT Patients, Adult Allo-SCT Survivor

In brief

The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.

Key facts

Study ID

NCT02812082

Run by

Memorial Sloan Kettering Cancer Center

People needed

0

Starts

2016-06-01

Last updated by the study team

2016-09-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK
• The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic
• Able to understand written and oral English

You may not qualify if…

• Patients less than 90 days post-transplant
• Patients without internet access
• Adult post-transplant patients who have relapsed prior to study recruitment

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.